Neurotech International (NTI) Stock Statistics & Valuation Metrics

Neurotech International has a market cap or net worth of AU$16.79M. The enterprise value is AU$12.71M.

Neurotech International has 1,049,622,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neurotech International’s return on equity (ROE) is -3.59 and return on invested capital (ROIC) is -375.29%.

The current PE Ratio of Neurotech International is ―. Neurotech International’s PEG ratio is -0.02.

In the last 12 months, Neurotech International had revenue of 2.44M and earned -10.60M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -9.02M and capital expenditures -4.00, giving a free cash flow of -9.02M billion.

Neurotech International pays an annual dividend of ―, resulting in a dividend yield of ―

Neurotech International upcoming earnings date is Mar 3, 2026, TBA (Confirmed).

Neurotech International as a current ratio of 11.34, with Debt / Equity ratio of 0.00%

In the past 12 months, Neurotech International has paid 0.00 in taxes.

Neurotech International EV to EBITDA ratio is -1.17, with an EV/FCF ratio of -1.39.

Neurotech International has AU$3.03M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$3.03M billion.

Gross margin is 100.00%, with operating margin of -453.62%, and net profit margin of -433.60%.

The average price target for Neurotech International is ―, which is 11.43% higher than the current price. The consensus rating is ―